OLIVER LEE

Allopathic & Osteopathic Physicians|Anesthesiology SEATTLE, WA NPI 1891292736

General Payments — all program years on this page

$3,578.46

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 30
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,152.95 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,827.9516
Consulting Fee $325.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $131.581
2023 $1,293.9312
2024 $2,152.9517

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078245649 Janssen Pharmaceuticals, Inc $150.00 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078829069 Janssen Biotech, Inc. $127.48 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097367859 Novo Nordisk Inc $125.00 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097801964 Novo Nordisk Inc $123.90 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104409353 AstraZeneca Pharmaceuticals LP $121.96 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104483974 AstraZeneca Pharmaceuticals LP $121.37 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115859818 Amgen Inc. $136.57 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115859827 Amgen Inc. $75.67 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115859837 Amgen Inc. $59.82 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127039775 Kyowa Kirin, Inc. $137.20 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139941579 GENZYME CORPORATION $118.80 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141860400 Merck Sharp & Dohme LLC $28.40 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145098318 Mallinckrodt Hospital Products Inc. $149.07 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146943326 Fresenius Kabi USA, LLC $88.92 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150258858 Getinge USA Sales, LLC $325.00 03/27/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1151752002 Teva Pharmaceuticals USA, Inc. $140.00 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151752084 Teva Pharmaceuticals USA, Inc. $123.79 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.